Quick Takeaways
- Winston Kung has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $237,184.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Winston Kung and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | Director | $159,750 | 11 Jun 2025 | ||
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | Director | $77,434 | 30 May 2025 | ||
| AVBP | ArriVent BioPharma, Inc. | Chief Financial Officer | 02 Feb 2026 | |||
| PMVP | PMV Pharmaceuticals, Inc. | Coo, Cfo | 12 May 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|